Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation-Reference-Cited by-同舟云学术

Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation

Published:2020-02-03 Issue:4 Volume:20 Page:1125-1136
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Sánchez‐Fueyo Alberto¹^ORCID,Whitehouse Gavin¹,Grageda Nathali²,Cramp Matthew E.³,Lim Tiong Y.¹^ORCID,Romano Marco²^ORCID,Thirkell Sarah⁴,Lowe Katie⁴,Fry Laura⁴,Heward Julie⁴,Kerr Alex⁴,Ali Jakia⁴,Fisher Chris⁴,Lewis Gillian⁴,Hope Andrew⁴,Kodela Elisavet¹,Lyne Mike⁴,Farzaneh Farzin⁵,Kordasti Shahram⁶,Rebollo‐Mesa Irene⁷,Jose Lozano Juan⁸,Safinia Niloufar²,Heaton Nigel¹,Lechler Robert⁴,Martínez‐Llordella Marc¹,Lombardi Giovanna²

Affiliation:

1. Institute of Liver Studies MRC Centre for Transplantation Department of Inflammation Biology Faculty of Life Sciences & Medicine King's College London London UK

2. MRC Centre for Transplantation Peter Gorer Department of Immunobiology Faculty of Life Sciences & Medicine King's College London London UK

3. Hepatology Research Group Plymouth University Peninsula Schools of Medicine and Dentistry Southwest Liver Unit Derriford Hospital Plymouth Hospitals NHS Trust Plymouth UK

4. NIHR Biomedical Research Centre Guy's and St Thomas' NHS Foundation Trust and King's College London London UK

5. School of Cancer and Pharmaceutical Sciences King's College London London UK

6. Systems Cancer Immunology Lab Comprehensive Cancer Centre King’s College London, & Haematology Department Guy’s Hospital London UK

7. Biostatistics Institute of Psychiatry, Psychology and Neuroscience King's College London London UK

8. Bioinformatic Platform Biomedical Research Center in Hepatic and Digestive Diseases (CIBEREHD) Instituto de Salud Carlos III Spain

Funder

Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.15700

Reference35 articles.

1. Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer

2. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity

3. T reg cells—the next frontier of cell therapy

4. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells

5. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of autologous regulatory T cell (Treg) therapy to prevent Cardiac Allograft Vasculopathy (CAV) in paediatric heart transplant recipients;Frontiers in Immunology;2024-09-09

2. Posttransplant complications: molecular mechanisms and therapeutic interventions;MedComm;2024-09

3. Activation and Regulation of Indirect Alloresponses in Transplanted Patients With Donor Specific Antibodies and Chronic Rejection;Transplant International;2024-08-20

4. Computational identification of novel potential genetic pathogenesis and otherwise biomarkers in acute liver allograft rejection;Heliyon;2024-08

5. Late Treatment With Autologous Expanded Regulatory T-cell Therapy After Alemtuzumab Induction Is Safe and Facilitates Immunosuppression Minimization in Living Donor Renal Transplantation;Transplantation;2024-06-07